QN-302 / Qualigen Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QN-302 / Qualigen Therap
NCT06086522: Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

Recruiting
1
54
US
QN-302
Qualigen Theraputics, Inc., Translational Drug Development
Solid Tumor
12/25
12/26

Download Options